Designs of Non-Inferiority and Biosimilar Clinical Trials
Publié le
IDDI organized a webinar on DESIGNS OF NON-INFERIORITY and BIOSIMILAR CLINICAL TRIALS. This webinar presented key concepts and current examples regarding…
Bayesian Study Design
Publié le
A Bayesian Study Design For Seamless Transition Between Phase II And Phase III Data collected by a sponsor suggested a…
Flexible Study Design
Publié le
A Flexible Study Design with Randomization to Placebo The maximum tolerated dose of a new drug, supposed to alleviate some…
Jumping Ahead to Phase III trial
Publié le
A new ophthalmic drug was going to enter a phase II dose-ranging trial in order to determine the dose to…
Biomarker-Based Clinical Trial Designs
Publié le
Free Webinar on Biomarker-Based Clinical Trial Designs The webinar on biomarker-based clinical trial designs reviewed of the recently proposed-designs, including adaptive…
Statistical Validation of Biomarkers
Publié le
IDDI organized its first free live webinar on STATISTICAL VALIDATION OF BIOMARKERS WATCH RECORDED WEBINAR TO ACCESS THE PRESENTATION OF THIS…
Using Minimization for a Complex Trial Design
Publié le
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…
Design and Analysis of Phase II Trials in Oncology
Publié le
IDDI organized a webinar on DESIGN AND ANALYSIS OF PHASE II TRIALS IN ONCOLOGY. This webinar presented key concepts and…
IDDI Announces The Appointment of Dr. Everardo Saad as Senior Medical Expert
Publié le
IDDI announces the appointment of Dr. Everardo Saad as Senior Medical Expert as of July 2014. Everardo brings over 12 years…
IDDI Reports Successful Partnership with Tigenix for Approval of Chondrocelect
Publié le
Successful Partnership with Tigenix for Approval of Chondrocelect for Cartilage Repair IDDI’s contributed statistical methodology towards approval of ChondroCelect® TiGenix’s…